We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

4091:TSENippon Sanso Holdings Corporation Analysis

Data as of 2026-08-25 - not real-time

¥5,653.00

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Nippon Sanso Holdings Corporation is priced at ¥5,653.00, and its moving averages give no clean directional read — the structure is neutral. The last 30 days have lost 6.9%. Momentum indicators put RSI at 38.2 (approaching oversold) with MACD reading bearish. Recent trading has carved out support near ¥5,521.00 and resistance around ¥6,200.00.
On valuation the read is fair — an earnings multiple of 19.8, absent a reliable peer benchmark. The average analyst target implies 11.9% above today's level. Revenue is growing at 14.9% on a 9.9% profit margin. The 1.16% dividend yield looks covered by current payout levels.
Risk scores 4 out of 10, which is moderate for this asset class. With 30-day volatility of 27.5%, a beta of 0.33 and a maximum drawdown of 21.9%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
This one splits by horizon — hold in the near term, buy further out, at 5/10 long-term conviction.

Top Market Events

Yahoo Finance6monNIPPON SANSO HOLDINGS CORPORATI 4091.MarketWatch3monNippon Sanso Holdings FY Net Y123.MarketWatch19dNippon Sanso Holdings 1Q Net Y43.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 4/10

Key Factors

  • Trading above the 200-day average of 5512.27
  • MACD momentum is negative
  • 30-day price change of -6.9%

Medium Term

1–3 years
Neutral
Model confidence: 4/10

Key Factors

  • Trading above the 200-day average of 5512.27
  • Analyst targets imply +11.9% versus the current price
  • MACD momentum is negative

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • Analyst targets imply +11.9% versus the current price
  • Revenue growth of +14.9%
  • P/E ratio of 19.8

Key Metrics & Analysis

Financial Health

Revenue Growth14.90%
Profit Margin9.90%
P/E Ratio19.8
ROE12.13%
ROA4.81%
Debt/Equity66.21
P/B Ratio1.9
Op. Cash Flow¥285.7B
Free Cash Flow¥135.0B

Technical Analysis

TrendNeutral
RSI38.2
Support¥5,521.00
Resistance¥6,200.00
MA 20¥5,884.70
MA 50¥5,908.62
MA 200¥5,512.28
MACDBearish
VolumeDecreasing
Fear & Greed Index93.84

Valuation

Fair Value¥5,773.60
Target Price¥6,325.00
Upside/Downside11.89%
GradeFair
TypeBlend
Dividend Yield1.16%

Risk Assessment

Beta0.33
Volatility27.50%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.